Found: 8
Select item for more details and to access through your institution.
Pharmacokinetics of Two Nanoemulsion Formulations of Δ<sup>8</sup>-Tetrahydrocannabinol in Rats.
- Published in:
- AAPS PharmSciTech, 2023, v. 24, n. 8, p. 1, doi. 10.1208/s12249-023-02699-1
- By:
- Publication type:
- Article
Pharmacokinetic/pharmaco-dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ<sup>9</sup>-tetrahydrocannabinol challenge tests.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 81, n. 4, p. 713, doi. 10.1111/bcp.12852
- By:
- Publication type:
- Article
Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 6, p. 846, doi. 10.1111/bcp.12141
- By:
- Publication type:
- Article
Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ<sup>9</sup>-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 1, p. 65, doi. 10.1111/bcp.12071
- By:
- Publication type:
- Article
Novel Δ<sup>9</sup>-tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
- Published in:
- British Journal of Clinical Pharmacology, 2012, v. 74, n. 1, p. 42, doi. 10.1111/j.1365-2125.2012.04164.x
- By:
- Publication type:
- Article
Review of delta‐8‐tetrahydrocannabinol (Δ<sup>8</sup>‐THC): Comparative pharmacology with Δ<sup>9</sup>‐THC.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 15, p. 3915, doi. 10.1111/bph.15865
- By:
- Publication type:
- Article
A Brief Background on Cannabis: From Plant to Medical Indications.
- Published in:
- Journal of AOAC International, 2019, v. 102, n. 2, p. 412, doi. 10.5740/jaoacint.18-0208
- By:
- Publication type:
- Article
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 9, p. 876, doi. 10.1177/02698811231190865
- By:
- Publication type:
- Article